logo
Identifying new targets for cancer therapy
Nanocarriers delivering RNAi to cancer cells
Targeting cancer cells with stem cell-like properties
Immunotherapy pioneer honored by Saudi Arabian Royalty
Testing on colon cancer vaccine is now underway
Adjuvant imatinib mesylate reduces risk of gastrointestinal stromal tumor recurrence
Approval of MEPACT® offers new treatment option for osteosarcoma sufferers
Arthritis and cholesterol drugs as potential treatments for prostate cancer
Bioengineered protein causes tumor regression in mouse model
Nitric oxide-coupled vitamin B12 produces ‘miracle’ results in dogs
Is dual antibody therapy with chemotherapy for metastatic colorectal cancer ready for prime time?
Biomarkers predict activity of anti-EGFR inhibitors in metastatic colorectal cancer
Bevacizumab for metastatic colorectal cancer
Recent advances in molecularly targeted therapy in advanced renal cell carcinoma
Advances in targeted therapies for metastatic colorectal cancer
New targeted therapies for non-small-cell lung cancer
Targeted therapy of glioblastomas
Targeted therapies in B-cell non-Hodgkin lymphomas
PATCAR
Drug may improve mobility in multiple sclerosis sufferers
Are arthritis drugs associated with an increased risk of shingles?
Daytime sleepiness in the elderly should alert clinicians to a potential risk of cardiovascular disease
Cytomegalovirus vaccine holds promise
UK trial provides encouraging results for ovarian cancer screening
Efficacy and safety of mometasone furoate nasal spray in allergic rhinitis, acute rhinosinusitis and nasal polyposis
Assessment of patient satisfaction with ebastine fast-dissolving tablets in patients suffering from allergic rhinitis
Rupatadine 10 and 20 mg are effective and safe in the treatment of perennial allergic rhinitis after 4 weeks of treatment
Treatment of atherosclerotic renal artery stenosis
Endosomal Toll-like receptors in autoimmunity
Acknowledgements